Max Chat
ASKA Pharmaceutical Holdings Co.,Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
8.37 | 112.41 | -92.56% | 8.2 | +2.07% |
| P/S |
|
1 | 75.54 | -98.67% |
|
|
| P/BV |
|
1.02 | 70.29 | -98.55% |
|
|
| P/FCF |
|
1210.3 | 28.67 | 4121.78% |
|
|
| Ev/Ebitda |
|
4.69 | 29.32 | -84.02% |
|
|
| Ev/S |
|
0.937 | 73.15 | -98.72% |
|
|
| Ev/FCF |
|
1784.39 | 27.26 | 6446.66% |
|
|
| E/P |
|
0.1889 | 0.4676 | -59.6% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
20 | -49.16 | -140.68% | 15.94 | +25.43% |
| ROE |
|
12.96 | 1.13 | 1043.86% |
|
|
| ROA |
|
8.48 | 0.6587 | 1187.83% |
|
|
| ROIC |
|
7.49 | 9.07 | -17.45% |
|
|
| ROS |
|
12.01 | -83.08 | -114.46% |
|
|
| ROCE |
|
15.99 | -1.97 | -912.84% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
9/10
|
0.7548 | 4.43 | -82.96% | 1.44 | -47.75% |
| Nеt Debt/Ebitda |
|
-0.3384 | 15.16 | -102.23% |
|
|
| Debt/Ratio |
|
0.1045 | 0.1487 | -29.72% |
|
|
| Debt/Equity |
|
0.4653 | 1.11 | -57.94% |
|
|
| Debt/Net Income |
|
1.26 | -2.47 | -150.94% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.95/10
|
3.18 | 2.86 | 11.05% | 2.25 | +41.43% |
| Number of years of dividend growth |
|
4 | 1.43 | 179.25% | ||
| DSI |
|
1 | 0.7453 | 34.17% |
|
|
| Average dividend growth |
|
49.72 | -140.78 | -135.32% |
|
|
| Average percentage for 5 years |
|
2.25 | 38.17 | -94.11% |
|
|
| Average percentage for payments |
|
21.92 | 34.62 | -36.69% |
|
|
| Difference from average difference in sector |
|
0.3164 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
19.61 | 1533.14 | -98.72% | ||
| Growth impulse Ebitda in 5 years |
|
138.46 | 3726.29 | -96.28% | ||
| Growth impulse Net Income in 5 years |
|
1062.56 | 2596.48 | -59.08% | ||
| Growth impulse FCF in 5 years |
|
-101.29 | 2353.76 | -104.3% | ||
| Growth impulse EPS in 5 years |
|
1061.66 | 3216.29 | -66.99% |
IP Score
6.74/10
